Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
CVS Caremark's decision is not in the best interest of patients, and heres why: Zepbound Demonstrates Superior Efficacy : Clinical evidence, most notably the head-to-head SURMOUNT-5 trial, showed that patients on Zepbound achieved significantly greater average weight loss (20.2%) compared to those on Wegovy (13.7%) over 72 weeks
Same molecules, same mechanism, entirely different philosophy
Smith GN, Brown P, Rogers SE, Eastoe J
Paid subscriptions are voluntary and all proceeds from them go to support Scripps Research
US$ 21.90
US$ 24.70
US$ 27.86
US$ 20.81
US$ 27.50
US$ 21.06
US$ 21.02
